News & Analysis as of

Environmental Social & Governance (ESG) Pharmaceutical Industry Risk Management

Hogan Lovells

2025 Horizons Life Sciences and Health Care

Hogan Lovells on

In 2025, Life Sciences and Health Care (LS&HC) companies face rapidly evolving regulatory paradigms that create transactional risks and require daily monitoring. After more than 70 national elections in 2024, the dust hasn’t...more

Paul Hastings LLP

Compliance as the Catalyst: ESG in Life Sciences

Paul Hastings LLP on

Like many companies in other sectors, Life Sciences companies recognize that corporate social responsibility (CSR)–evaluated and measured by independent rating organizations and based on their compliance with any applicable...more

Paul Hastings LLP

[Webinar] Survive or Thrive? Navigating the ESG Regulatory Landscape in Life Sciences - October 18th, 11:00 am - 12:00 pm ET

Paul Hastings LLP on

In the ever-evolving compliance landscape for life sciences companies, staying abreast of current trends and developing best practices to assess and mitigate risks is critical. Environmental, Social, and Governance (ESG)...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide